B
AGN

Baird’s Allergan plc AGN Stock Holding History

Baird’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$9.08M Buy
30,517
+9,353
+44% +$2.67M 0.09% 224
2014
Q4 		$5.45M Buy
21,164
+2,557
+14% +$639K 0.06% 316
2014
Q3 		$4.49M Sell
18,607
-12,558
-40% -$2.81M 0.06% 272
2014
Q2 		$6.95M Buy
31,165
+9,615
+45% +$1.99M 0.1% 197
2014
Q1 		$4.44M Sell
21,550
-565
-3% -$112K 0.06% 288
2013
Q4 		$3.71M Buy
22,115
+681
+3% +$106K 0.06% 328
2013
Q3 		$3.09M Buy
21,434
+2,734
+15% +$364K 0.06% 355
2013
Q2 		$2.36M Buy
+18,700
New +$2.12M 0.05% 386

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Baird's AGN Position: Q1 2015 in Review

Baird increased its Allergan plc (AGN) stake by 44% in Q1 2015, buying an estimated $2.67M and bringing the position to 30,517 shares worth $9.08M. The position accounts for 0.09% of the portfolio, ranked #224.

Baird first reported a position in AGN in Q2 2013 and has held it in 8 quarters since. 1,089 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Baird held 30,517 shares of Allergan plc worth $9.08M as of Q1 2015.
  • Baird bought 9,353 Allergan plc shares in Q1 2015, an estimated $2.67M.
  • Allergan plc made up 0.09% of Baird's portfolio in Q1 2015, its #224 holding.
  • Baird first reported a position in Allergan plc in Q2 2013 and has held it in 8 quarters since.
  • 1,089 funds tracked by Wall St. Rank held Allergan plc as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.